Showing 1 - 5 results of 5 for search 'Michael C. Repka', query time: 0.02s
Refine Results
-
1
Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation by Michael C. Repka, Nima Aghdam, Shaan K. Kataria, Lloyd Campbell, Simeng Suy, Sean P. Collins, Eric Anderson, Jonathan W. Lischalk, Brian T. Collins
Published 2017-10-01
Article -
2
High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation by Jonathan W. Lischalk, Meredith Akerman, Michael C. Repka, Astrid Sanchez, Christopher Mendez, Vianca F. Santos, Todd Carpenter, David Wise, Anthony Corcoran, Herbert Lepor, Aaron Katz, Jonathan A. Haas
Published 2024-02-01
Article -
3
Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer by Michael C. Repka, Tamir Sholklapper, Alan L. Zwart, Malika Danner, Marilyn Ayoob, Thomas Yung, Siyuan Lei, Brian T. Collins, Deepak Kumar, Simeng Suy, Ryan A. Hankins, Amar U. Kishan, Sean P. Collins
Published 2024-03-01
Article -
4
Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure by Justin Leu, Meredith Akerman, Christopher Mendez, Jonathan W. Lischalk, Jonathan W. Lischalk, Todd Carpenter, David Ebling, Jonathan A. Haas, Jonathan A. Haas, Matthew Witten, Marissa Barbaro, Paul Duic, Lee Tessler, Michael C. Repka
Published 2023-03-01
Article -
5
Corrigendum: Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure by Justin Leu, Meredith Akerman, Christopher Mendez, Jonathan W. Lischalk, Jonathan W. Lischalk, Todd Carpenter, David Ebling, Jonathan A. Haas, Jonathan A. Haas, Matthew Witten, Marissa Barbaro, Paul Duic, Lee Tessler, Michael C. Repka
Published 2023-04-01
Article